Related Experiment Videos
Elevated corticosteroid levels block the memory-improving effects of nootropics and cholinomimetics
C Mondadori1, T Ducret, A Häusler
1Ciba-Geigy Ltd., Pharmaceutical Research Department, Basle, Switzerland.
Psychopharmacology
|January 1, 1992
Summary
High steroid levels, like cortisol, can block the memory-enhancing effects of nootropics and other cognitive enhancers. This may explain why some Alzheimer's patients don't respond to these memory treatments.
Area of Science:
- Neuroscience
- Pharmacology
- Endocrinology
Background:
- Steroid hormones, such as aldosterone and corticosterone, play crucial roles in physiological processes.
- Nootropics (e.g., piracetam, pramiracetam) and cholinomimetics (e.g., physostigmine, tacrine) are known to enhance memory.
- Elevated cortisol levels are observed in Alzheimer's disease patients.
Purpose of the Study:
- To investigate the effect of elevated steroid levels on the memory-enhancing properties of various cognitive enhancers.
- To explore a potential common mechanism underlying the action of different memory-enhancing substances.
- To understand the implications of steroid dependency for therapeutic responses in cognitive decline.
Main Methods:
- Mice were orally pretreated with varying doses of aldosterone or corticosterone.
- The effects of subsequent administration of nootropics (piracetam, pramiracetam, aniracetam, oxiracetam) and cholinomimetics (physostigmine, arecoline, tacrine) on memory were assessed.
- Learning performance was evaluated to distinguish between memory enhancement and general learning impairment.
Main Results:
- Aldosterone and corticosterone pretreatment dose-dependently blocked the memory-enhancing effects of piracetam, pramiracetam, aniracetam, and oxiracetam.
- The memory improvements induced by physostigmine, arecoline, and tacrine (THA) were similarly inhibited by steroid pretreatment.
- These steroid treatments did not impair the animals' general learning performance.
Conclusions:
- Elevated levels of steroid hormones suppress the memory-enhancing effects of diverse cognitive enhancers, suggesting a common inhibitory pathway.
- This steroid dependency may explain the variable efficacy of nootropics and cholinomimetics in patients with cognitive disorders like Alzheimer's disease.
- Further research into the interaction between steroid hormones and cognitive enhancement mechanisms is warranted for targeted therapeutic strategies.